Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06587100 · ClinicalTrials.gov registry record
Wearable Activity Tracking to Curb Hospitalizations
A clinical trial of Malignant Solid Neoplasm and Hematopoietic Neoplasm, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 260
- Enrollment target
- 1
- Study location
NCT06587100 is a study of Malignant Solid Neoplasm and Hematopoietic Neoplasm that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 260 participants, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06587100, a study of Malignant Solid Neoplasm and Hematopoietic Neoplasm, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.
Conditions Studied
Interventions
- DEVICE Fitbit
- DEVICE Apple HealthKit-based devices
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2025-04-07 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06587100
The ClinicalTrials.gov registry entry for NCT06587100 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (77% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Fitbit is the first listed.
NCT06587100 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06587100 about?
NCT06587100 is a clinical study titled "Wearable Activity Tracking to Curb Hospitalizations". This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.
What is the current status of trial NCT06587100?
This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2025-04-07. Estimated completion is 2027-12-31.
What conditions does trial NCT06587100 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic Neoplasm, Lymphatic System Neoplasm.
What interventions are being tested in trial NCT06587100?
The interventions under investigation include: Fitbit (DEVICE), Apple HealthKit-based devices (DEVICE).
Who is sponsoring clinical trial NCT06587100?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06587100 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
RECRUITING
-
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Voices: Messages of Wisdom and Hope in the Face of Illness
RECRUITING
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.